Northrop Grumman Enters Contracts to Increase Missile Defense Production
Northrop Grumman signed two agreements totaling $3 billion to speed up production of missile interceptors.
----
Visa to Buy Fraud Defense Platform BioCatch in $2.4 Billion Deal
Visa is acquiring BioCatch, a fraud-reduction platform that uses artificial intelligence , for $2.4 billion in cash.
----
Lantheus Holdings to Be Acquired for Initial $6.7 Billion
Curium said it would pay $102.50 a share in cash for Lantheus, a 2.9% premium to Friday's closing price of $99.64 and 8.5% above Lantheus's closing price of $94.47 on May 21, before Bloomberg reported that Curium was circling the company.
----
KKR to Buy Integer Holdings for $4.3 Billion
Investment firm KKR has struck a deal to acquire medical-device outsourcing company Integer Holdings for $127 a share.
----
Rising Beef Costs Pressure Tyson's Bottom Line
The meatpacking company lowered its profit outlook for the year as a cattle shortage in the U.S. drives up expenses.
----
EchoStar's Hughes Network Files for Bankruptcy as $1.5B Debt Comes Due
Hughes Network Systems, owned by Charlie Ergen's EchoStar, filed for Chapter 11 bankruptcy on Sunday.
----
Kalshi Expands 15-Minute Markets Beyond Crypto With Gold and Silver
Kalshi is expanding its fast-growing 15-minute prediction markets to gold and silver as it works toward eventually offering similar contracts tied to individual stocks.
----
JPMorgan Chase to Invest $750 Billion to Boost U.S. Housing Supply, Homeownership
The bank aims to finance one million affordable housing units and provide loans to 200,000 first-time home buyers through 2035.
----
Marriott Says Middle East Conflict Weighed on Sales
The hotel company's second-quarter revenue rose 5% but fell short of analysts' estimates, as sales were weighed down by a drop in revenue per available room in the Middle East.
----
Banco BPM Pulls Out of Merger Talks With Monte Paschi
The move could clear the way for a rival $35 billion takeover offer from Intesa Sanpaolo.
----
AstraZeneca Shares Drop, Bristol Myers Squibb's Climb After Merger Talks Reports
A potential deal between AstraZeneca and Bristol Myers Squibb would create a pharma giant with a combined market value of roughly $400 billion.
----
Atkore Agrees to Be Bought by Prysmian for $3.8 Billion, Including Debt
Atkore shareholders will receive $95 a share in cash and Prysmian intends to combine its products with Atkore's to increase its exposure to North American data centers.
----
Record Exports Boost BYD Sales as Chinese EV Stocks Suffer
BYD exported over 180,000 vehicles in July, more than 40% of its total sales volume.
----
TotalEnergies Sells Stake in European Renewable Assets to KKR
TotalEnergies said it agreed to sell a 50% stake in European onshore solar and wind assets to private-equity firm KKR.
----
easyJet Extends Castlelake's Deadline to Top Apollo's $7.6 Billion Bid
The low-cost airline said Castlelake has until Friday to align its bid with that of rival Apollo.
----
Sandoz to Pay Around $480 Million to Settle U.S. Antitrust Pricing Litigations
The agreements mean the remaining claims against the Swiss maker of generic drugs in the U.S. generic antitrust litigation are those from individual plaintiffs.